The Valley Desk

NCT01877811 · Interventional trial

Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors

Overall registry status Completed

Phase 1

Conditions Solid Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov